The total number of NACDS RxIMPACT 2019 in-district events to promote DIR relief priorities now stands at 72—and counting.
Members of Congress were able to grasp firsthand critical pharmacy public policy issues when they toured pharmacies in their home states and congressional districts.
During the Fourth of July congressional recess, members of Congress learned firsthand about key pharmacy issues—particularly about the need for direct and indirect remuneration (DIR) fee relief as part of a drug-pricing legislative package.
NACDS emphasized the need for Congress to address direct and indirect remuneration (DIR) fee relief as it considers solutions to reduce healthcare costs.
NACDS recommended several measures to lower prescription drug prices and improve patient health--including DIR fee relief--to the House Committee on Energy and Commerce Subcommittee on Health.
Saturday, April 27 marks the DEA's National Drug Take Back Day. In the lead-up to that event, the FDA just launched a drug safety campaign aimed at opioid abuse prevention.
NACDS signed on to a letter supporting the Restoring Access to Medications Act, which would allow Americans to use the funds in their healthcare accounts to purchase over-the-counter (OTC) medications.
Former Speaker of the House of Representatives Paul Ryan (R-WI), Pulitzer Prize-winning author Doris Kearns Goodwin and Former Senator Jeff Flake (R-AZ) are set to speak at the 2019 NACDS Annual Meeting, April 27-30.
Rep. Ami Bera (D-CA) recognized the importance of pharmacists as accessible healthcare providers during a Costco pharmacy tour as part of the NACDS RxIMPACT program.